tiprankstipranks
Limes Schlosskliniken AG (DE:LIK)
XETRA:LIK
Germany Market

Limes Schlosskliniken AG (LIK) AI Stock Analysis

Compare
3 Followers

Top Page

DE:LIK

Limes Schlosskliniken AG

(XETRA:LIK)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
€500.00
▲(38.89% Upside)
Action:UpgradedDate:12/13/25
Limes Schlosskliniken AG's overall stock score reflects strong financial performance and stable valuation, balanced by mixed technical indicators. The company's robust revenue and profit growth, along with effective cash flow management, are significant strengths. However, technical analysis suggests potential caution due to bearish momentum indicators, and the valuation indicates moderate pricing relative to peers.
Positive Factors
Revenue Growth Track Record
A multi-year pattern of rising revenue provides a durable foundation for future cash generation and investment. Sustained top-line growth reflects expanding patient volumes or service mix in core care facilities, reducing execution risk and supporting reinvestment in capacity and quality over the next 2–6 months and beyond.
Negative Factors
Material Capital Expenditures
Sustained high capex pressures free cash flow despite improving operating cash generation. Over a 2–6 month horizon, continued heavy investment can constrain discretionary spending, increase reliance on external financing, and limit the speed at which cash reserves can be redeployed to other strategic priorities.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Track Record
A multi-year pattern of rising revenue provides a durable foundation for future cash generation and investment. Sustained top-line growth reflects expanding patient volumes or service mix in core care facilities, reducing execution risk and supporting reinvestment in capacity and quality over the next 2–6 months and beyond.
Read all positive factors

Limes Schlosskliniken AG (LIK) vs. iShares MSCI Germany ETF (EWG)

Limes Schlosskliniken AG Business Overview & Revenue Model

Company Description
LIMES Schlosskliniken AG operates private hospitals for psychiatry, psychotherapy, and psychosomatics services. It focuses on the treatment of stress-related illnesses, as well as mental and emotional disorders, such as depression, acute burnout, ...
How the Company Makes Money
Limes Schlosskliniken AG generates revenue primarily through its healthcare services, including inpatient and outpatient rehabilitation programs, which are often covered by health insurance. The company receives payments from statutory and private...

Limes Schlosskliniken AG Financial Statement Overview

Summary
Limes Schlosskliniken AG exhibits strong financial health with robust revenue and profit growth, efficient operations, and a stable balance sheet. The company demonstrates effective cash flow management, enhancing liquidity. While the debt level is manageable, continued focus on maintaining operational efficiency and prudent capital investment will be essential to sustain growth and mitigate risks.
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
80
Positive
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue41.87M37.45M37.17M28.81M23.43M11.02M
Gross Profit19.04M34.50M16.23M10.82M8.37M2.80M
EBITDA9.73M7.05M7.67M8.65M6.02M837.74K
Net Income4.60M3.11M3.40M4.20M3.94M-694.42K
Balance Sheet
Total Assets43.72M38.56M33.25M26.65M18.44M11.79M
Cash, Cash Equivalents and Short-Term Investments11.10M10.88M8.52M10.93M2.48M2.68M
Total Debt12.29M10.48M10.09M9.04M4.33M3.85M
Total Liabilities20.16M18.72M16.61M15.45M12.13M9.11M
Stockholders Equity22.05M18.33M15.13M11.10M6.31M2.68M
Cash Flow
Free Cash Flow627.04K2.48M-3.51M6.35M-1.83M-1.00M
Operating Cash Flow8.49M7.46M6.29M7.70M4.55M759.00K
Investing Cash Flow-7.71M-4.96M-9.79M-1.31M-6.38M-1.83M
Financing Cash Flow2.65M-159.15K1.09M2.04M1.40M2.53M

Limes Schlosskliniken AG Technical Analysis

Technical Analysis Sentiment
Positive
Last Price360.00
Price Trends
50DMA
472.70
Positive
100DMA
411.17
Positive
200DMA
390.25
Positive
Market Momentum
MACD
2.49
Positive
RSI
45.44
Neutral
STOCH
18.93
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:LIK, the sentiment is Positive. The current price of 360 is below the 20-day moving average (MA) of 497.20, below the 50-day MA of 472.70, and below the 200-day MA of 390.25, indicating a neutral trend. The MACD of 2.49 indicates Positive momentum. The RSI at 45.44 is Neutral, neither overbought nor oversold. The STOCH value of 18.93 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:LIK.

Limes Schlosskliniken AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
€260.37M6.0715.83%2.80%6.52%7.17%
73
Outperform
€142.80M8.5422.77%0.21%7.53%
65
Neutral
€171.95M2.4215.15%1.12%4.90%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
41
Neutral
€25.37M-1.8422.85%6.87%-94.85%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:LIK
Limes Schlosskliniken AG
476.00
190.00
66.43%
DE:MED
MEDICLIN
3.62
0.68
23.17%
DE:MAK
MATERNUS-Kliniken AG
1.21
-0.16
-11.68%
DE:EIF
Eifelhoehen-Klinik AG
3.18
1.77
125.53%
DE:JTH0
Gesundheitswelt Chiemgau AG
12.40
0.32
2.65%
DE:M12
M1 Kliniken AG
13.94
-0.45
-3.13%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 13, 2025